17 β-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats

Neurochemistry International

Volumn 48, Issue 5, 2006, Pages 367-373

  Túnez, Isaac ^a   Collado, Juan A ^b   Medina, Francisco J ^a   Peña, José ^a   Muñoz, María Del C ^a   Jimena, Ignacio ^a   Franco, Francisco ^a   Rueda, Ignacio ^a   Feijóo, Montserrat ^a   Muntané, Jordi ^b   Montilla, Pedro ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

17 Estradiol; 3 Nitropropionic acid; Cell death; Huntington's disease; Ovariectomy; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; CASPASE 3; ESTRADIOL; LACTATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DRUG EFFECT; FEMALE; GONADECTOMY; HUNTINGTON CHOREA; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL SURVIVAL; CONVULSANTS; CORPUS STRIATUM; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; ESTRADIOL; FEMALE; HUNTINGTON DISEASE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRO COMPOUNDS; OVARIECTOMY; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, WISTAR; SYNAPTOSOMES;

ANIMALIA;

EID: 33644655309     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.11.011     Document Type: Article

References (53)

1. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
2. M.F. Beal Aging, energy, and oxidative stress in neurodegenerative disease Ann. Neurol. 38 1995 357 366
3. M. Behl, T. Widmann, F. Trapp, and F. Holsboer 17 β-Estradiol protects neurons from oxidative stress-induced cell death in vitro Biochem. Biophys. Res. Commun. 216 1995 473 482
4. Z.K. Binienda Neuroprotective effects of l-carnitine in induced mitochondrial dysfunction Ann. N.Y. Acad. Sci. 993 2003 289 295
5. N. Bizat, J.M. Hermal, F. Boyer, C. Jacquard, C. Créminon, S. Ouary, C. Escartin, P. Hantraye, S. Krayewski, and E. Crouillet Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease J. Neurosci. 23 2003 5020 5030
6. C.V. Borlongan, T.K. Koutouzis, T.B. Freeman, D.W. Cahill, and P.R. Sanseberg Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Res. 697 1995 254 257
7. C.V. Borlongan, H. Nishino, and P.R. Sanberg Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease Neurosci. Res. 28 1997 185 189
8. M. Brouillet, P. Hantraye, R.J. Ferrante, R. Dolan, A. Leroy-Willig, N.W. Kowall, and M.F. Beal Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates Proc. Natl. Acad. Sci. U.S.A. 92 1995 7105 7109
9. J. Butterworth, C.M. Yates, and G.P. Reynolds Distribution of phosphate-activated glutaminase, succinic dehydrogesase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases J. Neurol. Sci. 67 1985 161 171
10. J. Butterworth, C.M. Yates, and J. Simpson Phosphate-activated in relation to Huntington's disease and agonal state J. Neurochem. 41 1983 440 447
11. G.M. Cohen Caspases: the executioners of apoptosis Biochem. J. 326 1997 1 16
12. D.E. Dluzen, J.L. Mcdermott, and B. Liu Estrogen alters MTPT-induced neurotoxicity in female mice; effects on striatal dopamine concentration and release J. Neurochem. 66 1996 356 359
13. J.A. Dykens, J.W. Simpkins, J. Wang, and K. Gordon Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism Exp. Gerontol. 38 2003 101 107
14. Y. Feng, J.D. Fratkins, and M.H. LeBlanc Estrogen attenuates hypoxic-ischemic brain injury in neonatal rats Eur. J. Pharmacol. 507 2005 77 86
15. L. Flohé, and W.A. Gunzler Assays of glutathione peroxidase Methods Enzymol. 105 1984 114 121
16. L.M. Garcia-Segura, I. Azcoitia, and L.L. DonCarlos Neuroprotection by estradiol Prog. Neurobiol. 63 2001 29 60
17. F.G. Gervais, D. Xu, G.S. Robertson, J.P. Vaillancourt, Y. Zhu, J. Huang, A. LeBlanc, D. Smith, M. Rigby, M.S. Shearman, E.E. Clarke, H. Zheng, L.H. Van Der Ploeg, S.C. Ruffolo, N.A. Thornberry, S. Xanthoudakis, R.J. Zamboni, S. Roy, and D.W. Nicholson Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation Cell 97 1999 395 406
18. M. Gu, M.T. Gash, V.M. Mann, F. Javoy-Agid, J.M. Cooper, and A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neurol. 39 1996 385 389
19. P.S. Harper P.S. Harper Huntington's Disease 1991 Saunders London
20. V. Henderson, A. Paganini-Hill, C. Emanuel, M. Dunn, and J. Buckwalter Estrogen replacement therapy in older women. Comparison between Alzheimer's disease cases and nondemented control subjects Arch. Neurol. 51 1994 896 900
21. P. Heron, and S. Daya 17β-Estradiol protects against quinolinic acid-induced lipid peroxidation in the rat brain Met. Brain Dis. 15 2000 267 274
22. G. Kroemer, and J.C. Reed Mitochondrial control of death Nat. Med. 6 2000 513 519
23. J. Kume-Kick, D.C. Ferris, I. Russo-Menna, and M.E. Rice Enhanced oxidative stress in female rat brain after gonadectomy Brain Res. 738 1996 8 14
24. M.A. La Fontaine, J.W. Geddes, A. Banks, and D.A. Butterfield 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease Brain Res. 858 2000 356 362
25. M.A. La Fontaine, J.W. Geddes, A. Banks, and D.A. Butterfield Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease J. Neurochem. 75 2000 1709 1715
26. M.A. La Fontaine, J.W. Geddes, and D.A. Butterfield 3-Nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington's disease Neurochem. Res. 27 2002 507 511
27. J.J. Lemasters, T. Qian, C.A. Bradham, D.A. Brenner, W.E. Cascio, L.C. Trost, Y. Nishimura, A.L. Nieminen, and B. Herman Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death J. Bioenerg. Biomembr. 31 1999 305 319
28. M.S. Levi, and M.A. Brimble A review of neuroprotective agents Curr. Med. Chem. 11 2004 2383 2397
29. R.L. Levine, D. Garland, C.N. Olivier, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman Determination of carbonyl content in oxidatively modified proteins Methods Enzymol. 186 1990 464 478
30. J.B. Martin, and J.F. Gusella Huntington's disease: pathogenesis and management N. Engl. J. Med. 315 1986 1267 1276
31. M.P. Mattson, N. Robinson, and Q. Guo Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1 Neuroreport 8 1997 3817 3821
32. i increase and cell damage in cultured rat cerebral endotelial cells. Brain Res. 956 2002 116 125
33. P. Montilla, I. Túnez, M.C. Muñoz, M. Salcedo, M. Feijóo, J.R. Muñoz-Castañeda, and I. Bujalance Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes Eur. J. Pharmacol. 488 2004 19 25
34. D.W. Nicholson, A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, N.A. Munday, S.M. Raju, M.E. Smulson, T.T. Yamin, V.L. Yu, and D.K. Miller Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376 1995 37 43
35. H. Nishino, H. Hida, M. Kumazaki, Y. Shimano, K. nakajima, H. Shimizu, T. Iowa, and H. baba The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability J. Neurotrauma. 17 2000 251 260
36. H. Nishino, K. Makajima, M. Kumazaki, A. Fukuda, K. Muramatsu, S.B. Deshpande, T. Inubushi, S. Morikawa, C.V. Borlongan, and P.R. Sanberg Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid Neurosci. Res. 30 1998 303 312
37. Z. Pang, and J.W. Geddes Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis J. Neurosci. 17 1997 3064 3073
38. Z. Pang, V. Bondada, T. Sengoku, R. Siman, and J.W. Geddes Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology J. Neuropathol. Exp. Neurol. 62 2003 633 643
39. Poumeau-Delille, G., 1953. Techniques biologiques en endocrinologie experimentale chez rat. Masson and Cie, Paris.
40. R. Radi, M. Rodrríguez, L. Castro, and R. Telleri Inhibition of mitochondrial electron transport by peroxynitrite Arch. Biochem. Biophys. 308 1994 89 95
41. S.W. Rau, D.B. Dubal, M. Böttner, L.M. Gerhold, and P.M. Wise Estradiol attenuates programmed cell death after stroke-like injury J. Neurosci. 23 2003 11420 11426
42. H. Sawada, M. Ibi, T. Kihara, M. Urushitani, A. Akaite, and S. Shimohama Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death J. Neurosci. Res. 54 1998 707 719
43. J.W. Simpkins, J. Wang, X. Wang, E. Pérez, L. Prokai, and J.A. Dykens Mitochondrial play a central role in estrogen-induced neuroprotection Curr. Drug Targets CNS Neurol. Disord. 4 2005 69 83
44. J.E. Springere, R.D. Azbill, and S.L. Carlson A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue Brain Res. Protoc. 2 1997 259 263
45. A. Strack, C.F. Duffy, M. Malvey, and E.A. Arriaga Individual mitochondrion characterization: a comparison of classical assays to capillary electrophoresis with laser-induced fluorescence detection Anal. Biochem. 294 2001 141 147
46. K.A. Strauss, and D.H. Morton Type I glutaric aciduria, part 2: a model of acute striatal necrosis Am. J. Med. Gen. Part C 121C 2003 53 70
47. R. Taffs, and M. Sitkovsky In vitro assays for mouse B and T lymphocyte function J.E. Coligan A.M. Kruisbeek D.H. Margulies E.M. Shevach W. Strober Current Protocols in Immunology 1991 Greene Publishing and Wiley Interscience New York 1 18
48. I. Túnez, P. Montilla, M.C. Muñoz, and R. Drucker-Colín Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes Eur. J. Pharmacol. 504 2004 169 175
49. I. Túnez, P. Montilla, M.C. Muñoz, M. Feijóo, and M. Salcedo Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease J. Pineal Res. 37 2004 252 256
50. I. Túnez, M.C. Muñoz, and P. Montilla Treatment with dehydroepiandrosterone prevents oxidative stress induced by 3-nitropropionic acid in synaptosomes Pharmacology 74 2005 113 118
51. G.T. Vatassery, J.C.K. Lai, E.G. DeMaster, W.E. Smith, and H.T. Quach Oxidation of vitamin E and vitamin C and inhabitation of brain mitochondrial oxidative phosphorylation by peroxynitrite J. Nuerosci. Res. 75 2004 845 853
52. J.C. Vis, R.T. de Boer-van Guisen, M.M. Verbeek, R.M. de Waal, H.J. ten Donkelaar, and B. Kremer 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures Neurosci. Lett. 329 2002 86 90
53. J. Wang, P.S. Green, and J.W. Simpkins Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitropropionic acid in SK-N-SH human neuroblastoma cells J. Neurochem. 77 2001 804 811